IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,298,142 | -30.6% | 346,396 | -65.7% | 0.04% | -25.0% |
| Q2 2023 | $19,149,893 | +26.9% | 1,009,483 | +3.8% | 0.05% | +11.6% |
| Q1 2023 | $15,089,214 | +138.1% | 972,870 | +172.5% | 0.04% | +115.0% |
| Q4 2022 | $6,337,407 | +339.2% | 357,037 | +38.1% | 0.02% | +300.0% |
| Q3 2022 | $1,443,000 | -32.8% | 258,567 | -53.0% | 0.01% | -28.6% |
| Q2 2022 | $2,146,000 | -52.6% | 550,383 | -33.0% | 0.01% | -46.2% |
| Q1 2022 | $4,528,000 | -37.7% | 821,869 | -3.7% | 0.01% | -18.8% |
| Q4 2021 | $7,272,000 | -26.9% | 853,528 | -25.4% | 0.02% | -27.3% |
| Q3 2021 | $9,944,000 | -26.2% | 1,144,311 | -10.3% | 0.02% | -29.0% |
| Q2 2021 | $13,478,000 | +9.0% | 1,275,149 | +65.5% | 0.03% | -3.1% |
| Q1 2021 | $12,360,000 | +717.5% | 770,565 | +2253.9% | 0.03% | +700.0% |
| Q4 2020 | $1,512,000 | -28.8% | 32,736 | -45.8% | 0.00% | -50.0% |
| Q3 2020 | $2,124,000 | +852.5% | 60,345 | +559.7% | 0.01% | +700.0% |
| Q2 2020 | $223,000 | – | 9,147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |